Synthetic method of bosutinib intermediate

A technology of bosutinib and a synthesis method, applied in the field of chemistry, can solve the problems of increased environmental protection pressure, difficult recycling and application, and high boiling point difference, and achieves the effects of convenient post-processing and purification, good reaction selectivity, and easy removal.

Active Publication Date: 2020-05-08
JIANGSU YUANDA XIANLE PHARMA +1
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] In the existing synthesis process, the first step is to use a mixture of acetic acid and acetic anhydride for acetylation reaction. The boiling point of acetic acid is 117.9°C, and the boiling point of acetic anhydride is 139.8°C. Relatively high; the four

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthetic method of bosutinib intermediate
  • Synthetic method of bosutinib intermediate
  • Synthetic method of bosutinib intermediate

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0037] Example 1

[0038] Synthesis method of bosutinib intermediate, bosutinib intermediate is 2,4-dichloro-5-methoxyaniline. In a 3000mL three-necked flask, add 545g of formic acid, turn on the stirring, and add m-aminophenol in batches 109g (1.0mol), 1.82g (10mmol) of vanadium pentoxide, heated to 100℃, TLC monitored the completion of the reaction (PE:EA=1:1), cooled to room temperature, in about 3h, chlorine gas was introduced to react, the color It turns to light yellow, and the reaction is completed monitored by dot plate (PE:EA=1:1). After the reaction is over, it is filtered, and the filtrate is recycled for recycling. The intermediate is directly subjected to the next reaction without purification. Add 1500mL of dimethylformamide and 207.3g (1.5mol) of potassium carbonate to the reaction flask containing 2,4-dichloro-5-carboxamidophenol from which formic acid has been recovered. Stir for 30min at 40℃, and add dropwise for about 1h. 189.2 g (1.5 mol) of dimethyl sulfat...

Example Embodiment

[0041] Example 2

[0042] Into a 3000mL three-necked flask, add 1417g of formic acid, start stirring, add 109g (1.0mol) of m-aminophenol and 16.2g (70mmol) of tungsten trioxide in batches, heat to 50℃, TLC monitors the completion of the reaction (PE:EA=1: 1), then cool to 20° C., cool to room temperature, add 337.4 g (2.5 mol) of sulfonyl chloride dropwise, after the dropwise addition, the color gradually changes to light yellow, and the dot plate monitors the completion of the reaction (PE:EA=1:1). After the reaction is over, it is filtered, and the filtrate is recycled for recycling. Add appropriate amount of dichloroethane to the reaction flask from which the formic acid has been recovered, dissolve it, wash with water until it is neutral, and concentrate to obtain crude 2,4-dichloro-5-carboxamidophenol. Without purification, proceed directly to the next reaction. Transfer all the obtained crude 2,4-dichloro-5-carboxamidophenol to a 3000mL autoclave, add 1090g of acetonitrile...

Example Embodiment

[0044] Example 3

[0045] Into a 3000mL three-necked flask, add 1090g of formic acid, start stirring, add 109g (1.0mol) of m-aminophenol and 9.1g (50mmol) of vanadium pentoxide in batches, heat to 70℃, TLC monitors the completion of the reaction (PE:EA=1 :1), then cool to 40°C, add 175.3g (3.0mol) of sodium chloride in batches, add 510.2g (4.5mol) of 30% hydrogen peroxide dropwise within 30min, and monitor the completion of the reaction by TLC (PE:EA=1:1) After the reaction is over, filter and recycle formic acid from the filtrate. The intermediate is directly subjected to the next reaction without purification. Add 1500 mL of propanol, 165.9 g (1.2 mol) of potassium carbonate, and stirring for 30 min at 40°C into the 3000 mL reaction flask containing 2,4-dichloro-5-carboxamidophenol after the recovery of formic acid. 151.4 g (1.2 mol) of methyl ester, heated to 50° C., and continued stirring for 1 h to obtain a white suspension. Pour the reaction solution into an ice-water mi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a synthetic method of a bosutinib intermediate. The method comprises the following steps: reacting m-aminophenol with formic acid to generate 3-formamido phenol; carrying outa benzene ring chlorination reaction on 2, 4-dichloro-5-carboxamido phenol to generate 2, 4-dichloro-5-carboxamido phenol, carrying out a phenolic hydroxyl methylation reaction on the 2, 4-dichloro-5-carboxamido phenol to generate 2, 4-dichloro-5-carboxamido anisole, and removing formyl by using illumination to generate 2, 4-dichloro-5-methoxyaniline. The method has the advantages of mild reactionconditions, good selectivity, high yield, no need of purification of the intermediate, easily available raw materials, environmental protection, simplicity, high efficiency, energy saving, reductionof the production cost, improvement of the operation environment, simple operation, high automation degree, and especially easy realization of industrialization.

Description

technical field [0001] The invention relates to the technical field of chemistry, and specifically provides a method for synthesizing a bosutinib intermediate. Background technique [0002] The chemical name of Bosutinib is 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1 -piperazine)propoxyl]-3-quinolinecarbonitrile is a potent protein kinase Scr / Ab1 dual inhibitor, its inhibitory effect is stronger than imatinib, both can inhibit the The autophosphorylation of Src protein also has high anti-proliferative activity, which can inhibit the proliferation and survival of CML cells. It is mainly used for patients with Ph chromosome-positive CML in chronic phase, accelerated phase or blast phase who are intolerant or resistant to other treatments including imatinib. Bosutinib is a good alternative drug. Adverse reactions were within acceptable range. It has been confirmed by clinical trials that bosutinib is effective against a variety of tumors, including bre...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07C231/02C07C231/12C07C233/25C07C213/02C07C217/84B01J23/22B01J23/28B01J23/30
CPCC07C231/02C07C231/12C07C213/02B01J23/22B01J23/28B01J23/30C07C233/25C07C217/84
Inventor 刘年金胡丽娟张邦国赵百合杜艳
Owner JIANGSU YUANDA XIANLE PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products